Company:  UNITY BIOTECHNOLOGY, INC. (UBX)
Form Type:  4
Filing Date:  6/19/2019 
CIK:  0001463361 
Address:  3280 BAYSHORE BOULEVARD 
City, State, Zip:  BRISBANE, California 94005 
Telephone:  (415) 328-5504 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$7.62  
Change: 
0.03 (0.40%)  
Trade Time: 
11:06 AM EST  
Market Cap: 
$326.95M
Trade UBX now with

© 2019  
Description of Business
Overview Our mission is to extend human healthspan. We define healthspan, or healthy longevity, as the period of one's life unburdened by the diseases of aging. Enabled by foundational scientific insights, we have devoted over seven years to identifying multiple mechanisms that we believe to be root causes of age-related disease. We are utilizing these insights to develop a broad portfolio of drug candidates to treat these diseases of aging, and we initiated our first clinical study of our lead drug candidate in the second quarter of 2018. We believe our team of scientific, clinical, and business leaders, and our strong culture of collaboration with external scientists make us uniquely qualified to accomplish our ambitious mission. Age-related diseases such as arthritis, vision loss, and cognitive decline cause considerable economic, personal, and societal burden.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES